| __timestamp | Intra-Cellular Therapies, Inc. | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 21226345 | 396000000 |
| Thursday, January 1, 2015 | 87718074 | 364000000 |
| Friday, January 1, 2016 | 93831530 | 376000000 |
| Sunday, January 1, 2017 | 79419009 | 382000000 |
| Monday, January 1, 2018 | 132166913 | 432000000 |
| Tuesday, January 1, 2019 | 89124838 | 457000000 |
| Wednesday, January 1, 2020 | 65782137 | 463000000 |
| Friday, January 1, 2021 | 88845513 | 508000000 |
| Saturday, January 1, 2022 | 134715000 | 539000000 |
| Sunday, January 1, 2023 | 180142000 | 614000000 |
| Monday, January 1, 2024 | 686000000 |
Unleashing the power of data
In the ever-evolving landscape of pharmaceutical research, the investment in Research and Development (R&D) is a critical indicator of a company's commitment to innovation. Over the past decade, Zoetis Inc. and Intra-Cellular Therapies, Inc. have demonstrated contrasting strategies in their R&D expenditures.
From 2014 to 2023, Zoetis Inc. consistently allocated a significant portion of its resources to R&D, with a notable increase of approximately 55% in spending, peaking in 2023. This reflects Zoetis's robust pipeline and commitment to advancing animal health solutions. In contrast, Intra-Cellular Therapies, Inc. showed a more volatile R&D investment pattern, with a remarkable 750% increase from 2014 to 2023, underscoring its aggressive pursuit of breakthroughs in mental health therapies.
These trends highlight the diverse approaches within the pharmaceutical industry, where strategic R&D investments can drive innovation and market leadership.
Research and Development: Comparing Key Metrics for Amgen Inc. and Intra-Cellular Therapies, Inc.
Analyzing R&D Budgets: Zoetis Inc. vs Takeda Pharmaceutical Company Limited
R&D Insights: How Zoetis Inc. and Sarepta Therapeutics, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Halozyme Therapeutics, Inc.
Comparing Innovation Spending: Zoetis Inc. and Ultragenyx Pharmaceutical Inc.
Analyzing R&D Budgets: Zoetis Inc. vs Viking Therapeutics, Inc.
Zoetis Inc. vs ADMA Biologics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Zoetis Inc. and Travere Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Amphastar Pharmaceuticals, Inc.
R&D Spending Showdown: Viatris Inc. vs Intra-Cellular Therapies, Inc.
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs ACADIA Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Intra-Cellular Therapies, Inc. and Ligand Pharmaceuticals Incorporated